Plus   Neg

Toyota's Woven Planet Buys Lyft's Self-Driving Car Division For $550 Mln

Toyota Motor Corp.'s (TM) subsidiary Woven Planet Holdings Inc. has agreed to acquire ride-hailing service Lyft Inc.'s (LYFT) self-driving vehicle division, Level 5, for $550 million in cash.

Lyft will receive $200 million in upfront payment and the rest $350 million in payments over a five-year period. Lyft also expects the deal to remove $100 million of operating expenses from its R&D division. The transaction is expected to close in the third quarter of 2021.

"Assuming the transaction closes within the expected timeframe and the COVID recovery continues, we are confident that we can achieve Adjusted EBITDA profitability in the third quarter of this year," Lyft Co-Founder and President John Zimmer said.

The deal also includes multi-year non-exclusive commercial agreements between Lyft and Woven Planet. About 300 people from Lyft Level 5 will be integrated into Woven Planet. The Level 5 team will continue to operate out of its office in Palo Alto, California.

LYFT closed Monday's trading at $63.06, down $0.64 or 1.00%, on the Nasdaq. The stock, however, gained $1.49 or 2.36%, in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fashion retailer L Brands, Inc. announced Tuesday that its Board of Directors has unanimously approved a plan to separate the company into two independent publicly traded companies. The two public companies will be Bath & Body Works, one of the world's leading bath, body and home fragrance retailers, and Victoria's Secret, including Victoria's Secret Lingerie, PINK and Victoria's Secret Beauty. Danish pharmaceutical company Novo Nordisk A/S is recalling 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy to the consumer level, due to improper storage temperature conditions, the U.S. Food and Drug Administration said. The Food and Drug Administration on Monday expanded the emergency use authorization of Pfizer-BioNTech's Covid-19 vaccine to include 12- to 15-year-olds. "The FDA's expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age...
Follow RTT